J B Chemicals and Pharmaceuticals Share Price | J B Chemicals and Pharmaceuticals Stock Screener
JBCHEPHARM
Pharmaceuticals
Share Price NSE
₹2204.20
▲
14.20 (0.65%)
Share Price BSE
₹2202.15
▲
13.35 (0.61%)
As of May 27, 2026, the J B Chemicals and Pharmaceuticals share price (NSE: JBCHEPHARM) is ₹2,204.20 on NSE and ₹2,202.15 on BSE, up 0.65% from the previous close, with shares trading between ₹2,168.00 and ₹2,215.00, and a 52-week range of ₹1,608.60–₹2,228.40.
Check JBCHEPHARM 52-week high low for the annual price range and momentum.
Use the J B Chemicals and Pharmaceuticals stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
J B Chemicals and Pharmaceuticals Market Cap
₹35,390.35 Cr.
JBCHEPHARM P/E Ratio (TTM)
49.53
J B Chemicals and Pharmaceuticals P/B Ratio
8.45
EPS (TTM)
₹45.16
Dividend Yield
0.43%
Debt to Equity
0.06
JBCHEPHARM 52 Week High
₹2228.40
J B Chemicals and Pharmaceuticals 52 Week Low
₹1608.60
Operating Margin
19.00%
Profit Margin
11.03%
JBCHEPHARM Revenue (TTM)
₹916.00
EBITDA
₹186.00
Net Income
₹101.00
Total Assets
₹4,969.00
Total Equity
₹4,159.00
J B Chemicals and Pharmaceuticals Share Price Chart
Screen J B Chemicals and Pharmaceuticals share price with an interactive chart. Analyse JBCHEPHARM price trends and volatility across different timeframes.
J B Chemicals and Pharmaceuticals Company Profile - Fundamental Screener
Screen J B Chemicals and Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JBCHEPHARM shares.
J.B. Chemicals & Pharmaceuticals Limited is an Indian pharmaceutical company founded in 1976. It manufactures and markets a range of pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. The company specializes in gastroenterology, hypertension, and dermatology, with additional focus on nephrology, respiratory, virology, diabetes, and nicotine replacement therapy. Key brands...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Arun Duggal
ISIN
INE572A01036
Website
https://www.jbpharma.com
J B Chemicals and Pharmaceuticals Balance Sheet Screener
Screen JBCHEPHARM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 4,969 | 4,274 | 3,994 | 3,554 | 2,607 | 2,238 | 1,821 | 1,792 | 1,765 | 1,674 |
| Current Assets | 2,909 | 1,923 | 1,853 | 1,528 | 1,253 | 1,553 | 1,073 | 1,051 | 1,047 | 795 |
| Fixed Assets | 1,902 | 1,968 | 2,004 | 1,901 | 1,277 | 634 | 651 | 621 | 640 | 679 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 218 | 208 | 203 | 519 | 85 | 79 | 69 | 65 | 46 | 27 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4,159 | 3,433 | 2,923 | 2,480 | 2,139 | 1,813 | 1,438 | 1,483 | 1,444 | 1,366 |
| Share Capital | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 16 | 17 | 17 |
| Reserves & Surplus | 4,143 | 3,418 | 2,908 | 2,465 | 2,119 | 1,794 | 1,420 | 1,464 | 1,425 | 1,347 |
J B Chemicals and Pharmaceuticals Income Statement Screener - Profit & Revenue Analysis
Screen J B Chemicals and Pharmaceuticals income statement and profit fundamentals.
Analyze JBCHEPHARM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for J B Chemicals and Pharmaceuticals share price evaluation.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 916 | 964 | 1,109 | 1,100 | 1,083 | 878 | 1,010 | 1,011 | 972 | 767 | 902 | 889 | 852 | 627 | 786 |
| Expenses | 730 | 723 | 793 | 775 | 769 | 664 | 724 | 730 | 709 | 599 | 664 | 638 | 621 | 500 | 612 |
| EBITDA | 186 | 241 | 315 | 325 | 314 | 215 | 286 | 281 | 263 | 168 | 238 | 251 | 231 | 127 | 174 |
| Operating Profit % | 19.00% | 24.00% | 28.00% | 29.00% | 28.00% | 23.00% | 28.00% | 27.00% | 26.00% | 21.00% | 26.00% | 28.00% | 26.00% | 20.00% | 22.00% |
| Depreciation | 50 | 46 | 43 | 44 | 45 | 41 | 41 | 42 | 42 | 32 | 31 | 32 | 34 | 22 | 26 |
| Interest | 1 | 2 | 1 | 1 | 2 | 9 | 6 | 2 | 3 | 14 | 12 | 10 | 13 | 2 | 6 |
| Profit Before Tax | 135 | 193 | 272 | 279 | 267 | 165 | 240 | 237 | 218 | 123 | 194 | 209 | 184 | 103 | 142 |
| Tax | 33 | 47 | 69 | 71 | 69 | 38 | 63 | 62 | 56 | 35 | 52 | 58 | 50 | 18 | 37 |
| Net Profit | 101 | 146 | 202 | 208 | 198 | 126 | 177 | 175 | 163 | 88 | 142 | 151 | 134 | 85 | 105 |
| EPS | 6.35 | 9.36 | 12.99 | 13.29 | 12.63 | 8.22 | 11.39 | 11.24 | 10.46 | 11.33 | 9.20 | 9.72 | 8.62 | 10.98 | 13.59 |
J B Chemicals and Pharmaceuticals Cash Flow Screener - Liquidity Fundamentals
Screen JBCHEPHARM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 903 | 801 | 626 | 170 | 315 | 276 | 194 | 123 | 201 | 140 |
| Investing Activities | -296 | -404 | -962 | 2 | -231 | 24 | -28 | -21 | -45 | -26 |
| Financing Activities | -580 | -386 | 357 | -138 | -87 | -306 | -156 | -60 | -184 | -100 |
| Net Cash Flow | 27 | 11 | 20 | 34 | -3 | -6 | 11 | 43 | -28 | 15 |
J B Chemicals and Pharmaceuticals Shareholding Pattern Screener
See J B Chemicals and Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings.
Check J B Chemicals and Pharmaceuticals promoter holding and ownership changes for JBCHEPHARM on TickJournal.
| Item | 2026-Mar | 2026-Jan | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 48.80% | 48.78% | 47.55% | 47.56% | 47.73% | 47.84% | 53.66% | 53.74% |
| FII Holding | 16.33% | 14.56% | 14.88% | 15.30% | 17.77% | 18.30% | 14.64% | 13.63% |
| DII Holding | 21.38% | 22.71% | 23.36% | 22.83% | 19.63% | 18.72% | 16.41% | 16.81% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% |
| Public Holding | 11.77% | 12.03% | 12.37% | 12.47% | 13.04% | 13.28% | 13.42% | 13.87% |
| Other Holding | 1.71% | 1.92% | 1.85% | 1.84% | 1.83% | 1.86% | 1.87% | 1.94% |
| Shareholder Count | 74,043 | 68,966 | 69,338 | 71,957 | 70,064 | 63,948 | 62,081 | 62,743 |
J B Chemicals and Pharmaceuticals Share Dividend Screener - Share Yield Analysis
Check J B Chemicals and Pharmaceuticals dividend history with payout and yield data.
View J B Chemicals and Pharmaceuticals dividend details including ex-dates and amounts for JBCHEPHARM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹15.50 | 0.75% |
| 2024-March | ₹12.25 | 0.75% |
| 2023-March | ₹17.75 | 1.08% |
| 2022-March | ₹16.50 | 1.67% |
| 2021-March | ₹16.50 | 2.10% |
| 2020-March | ₹11.00 | 1.75% |
| 2019-March | ₹5.00 | 1.96% |
| 2018-March | ₹2.00 | 1.10% |
| 2017-March | ₹1.00 | 0.64% |
J B Chemicals and Pharmaceuticals Stock Index Membership
See which indices include J B Chemicals and Pharmaceuticals stock.
Check JBCHEPHARM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY MNC
NIFTY MULTI MFG
NIFTY PHARMA
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 250
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
J B Chemicals and Pharmaceuticals Market Events Screener - Corporate Actions
Get J B Chemicals and Pharmaceuticals corporate actions including splits, bonuses, and buybacks.
Check J B Chemicals and Pharmaceuticals stock events that may affect JBCHEPHARM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2023-05-24 | Split | 1:2 | 0.00% | |
| Dividend | ₹ 8.00 /share | 10.40% | ||
| 2026-06-17 | 2026-06-17 | Annual General Meeting | NA | -0.12% |
| 2026-05-11 | 2026-05-11 | Quarterly Result Announcement | NA | 3.25% |
| 2026-04-28 | 2026-04-28 | Extraordinary General Meeting | NA | -1.68% |
| 2026-02-11 | 2026-02-11 | Dividend | ₹ 12.70 /share | 1.60% |
| 2026-01-16 | 2026-01-16 | Quarterly Result Announcement | NA | 4.16% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 6.12% |
| 2025-08-06 | 2025-08-06 | Annual General Meeting | NA | 4.95% |
| 2025-07-30 | 2025-07-30 | Dividend | ₹ 7.00 /share | 14.10% |
| 2025-07-30 | 2025-07-30 | Quarterly Result Announcement | NA | 9.13% |
| 2025-05-14 | 2025-05-14 | Quarterly Result Announcement | NA | -4.75% |
| 2025-02-07 | 2025-02-08 | Dividend | ₹ 8.50 /share | -2.35% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | -5.04% |
| 2024-11-06 | 2024-11-06 | Quarterly Result Announcement | NA | -2.31% |
J B Chemicals and Pharmaceuticals Competitors Screener - Peer Comparison
Screen JBCHEPHARM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 442,509 | 38.37 | 58,220 | 6.38% | 11,565 | 54.66 |
| Divis Laboratories | 180,452 | 69.82 | 10,560 | 8.73% | 2,520 | 59.28 |
| Torrent Pharmaceuticals | 153,580 | 70.46 | 13,753 | 19.18% | 2,028 | 60.91 |
| Cipla | 114,559 | 29.64 | 27,712 | -2.46% | 3,783 | 64.86 |
| Dr Reddys Laboratories | 110,089 | 26.69 | 33,593 | -0.44% | 3,998 | 54.22 |
| Zydus Life Science | 109,257 | 21.19 | 26,720 | 13.65% | 5,242 | 75.42 |
| Lupin | 104,041 | 19.33 | 27,488 | 19.98% | 5,345 | 46.91 |
| Mankind Pharma | 99,915 | 51.52 | 14,278 | 12.03% | 1,750 | 55.29 |
| Aurobindo Pharma | 83,397 | 24.27 | 33,385 | 3.21% | 3,376 | 47.24 |
| Laurus Labs | 74,592 | 83.31 | 6,813 | 21.03% | 884 | 80.70 |
J B Chemicals and Pharmaceuticals Company Announcements - News Screener
Screen JBCHEPHARM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| Letter To Shareholders - Integrated Annual Report 2025-26 | - | |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-27 | Business Responsibility and Sustainability Reporting (BRSR) | - |
| 2026-05-27 | Reg. 34 (1) Annual Report. | - |
| 2026-05-27 | Intimation Of Notice Of AGM To Be Held On June 17 2026 | - |
| 2026-05-24 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-23 | Intimation Of Record Date | - |
| 2026-05-22 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-05-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-11 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-11 | Corporate Action-Board approves Dividend | - |
| 2026-05-11 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-05-11 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-05-07 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-05-05 | Board Meeting Intimation for Meeting Of The Board Of Directors Will Be Held On May 11 2026 | - |
| 2026-04-28 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-28 | Shareholder Meeting / Postal Ballot-Outcome of Court Convened Meeting | - |